Acriptega 50mg/300mg/300mg Tablets in Kenya

Acriptega 50mg/300mg/300mg Tablets in Kenya

KSh 7,500.00

Acriptega is a trusted antiretroviral therapy (ART) used in the management of HIV infection. It is a once-daily, fixed-dose combination of Dolutegravir (50mg), Lamivudine (300mg), and Tenofovir Disoproxil Fumarate (300mg). Manufactured by Mylan, this treatment is highly effective in suppressing HIV viral load and improving immune function.

Acriptega 50mg/300mg/300mg Tablets in Kenya

KSh 7,500.00

Add to cart
Buy Now

Overview:
Acriptega is a trusted antiretroviral therapy (ART) used in the management of HIV infection. It is a once-daily, fixed-dose combination of Dolutegravir (50mg), Lamivudine (300mg), and Tenofovir Disoproxil Fumarate (300mg). Manufactured by Mylan, this treatment is highly effective in suppressing HIV viral load and improving immune function.

Key Benefits:

  • Powerful HIV treatment – Combines three ARVs in one convenient tablet.

  • Once-daily dosage – Easy to take, improving treatment adherence.

  • Viral suppression – Helps reduce HIV viral load to undetectable levels.

  • Boosts immunity – Supports immune system recovery.

  • WHO-recommended – Part of global guidelines for HIV treatment.

Product Details:

  • Brand: Acriptega

  • Active Ingredients: Dolutegravir 50mg + Lamivudine 300mg + Tenofovir Disoproxil Fumarate 300mg

  • Pack Size: 90 tablets (3-month supply)

  • Manufacturer: Mylan

  • Dosage: One tablet daily, as prescribed by your doctor

Safety & Usage:

  • For adults and adolescents (weighing ≥40kg).

  • Take daily at the same time with or without food.

  • Do not skip doses to avoid resistance.

  • Always use under medical supervision.

Possible Side Effects:
May include headache, nausea, insomnia, or fatigue. Rarely, it can affect kidney or liver function – regular monitoring is advised.

Reviews

There are no reviews yet.

Be the first to review “Acriptega 50mg/300mg/300mg Tablets in Kenya”

Your email address will not be published. Required fields are marked *

Top